Company snapshot
Market Cap
$207B
Mega-cap2016 — today
10-Year Price
+100%
2016 — today
52-Week Range
$118.15$165.61
Current $165.61· 100%
Featured in rankings
S&P500NASDAQBest Healthcare Dividend StocksMost Undervalued Dividend StocksBest High-Yield Dividend Stocks
Rankings recomputed after each US market close — see where GILD stands against peers.
Similar companies
| Company | P/E | Div yield |
|---|---|---|
| ABTAbbott Laboratories | 38.7 | 2.4% |
| NVONovo Nordisk A/S | 10.0 | 4.6% |
| AMGNAmgen Inc. | 28.6 | 2.2% |
| PFEPfizer Inc. | 39.6 | 5.7% |
| DHRDanaher Corporation | 38.8 | 0.6% |
| TMOThermo Fisher Scientific Inc. | 37.4 | 0.3% |
| ISRGIntuitive Surgical, Inc. | 53.9 | — |
| AZNAstraZeneca PLC | 26.2 | 1.9% |
Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.
Valuation in context
P/E ratio
-52.4
N/A
Not meaningful — company is unprofitable
Sector median 25.2below sector
EV / EBITDA
972.7
Near historic high
Near historic highs — last 10 years
Sector median 15.4above sector
Dividend Yield
2.0%
Near historic low
Near historic low — last 10 years
Sector median 1.8%above sector
FCF Yield
6.9%
Historically low
Historically low relative to the last 10 years
Sector median -12.6%above sector